weight loss drug is the single most important factor in determining whether your Medicare plan in Washington State will cover Ozempic
While the FD&C Act provides the framework for drug approval and regulation in the U.S., the current trend of using Ozempic for weight loss demonstrates how consumer behavior can sometimes outpace regulatory intent
If you are considering switching due to plateau, exploring why you are not losing weight on your current medication may reveal other factors at play
For those in the semaglutide group, the weight-loss trajectory continued to week 65 and then was sustained for the study period through week 208 (10.2% for the semaglutide group, 1.5% for the placebo group
If you do not wish to become pregnant, blood work should include a pregnancy test before starting and periodic testing thereafter
After first use, keep refrigerated and use within protocol timeframe